Health'Monoclonal Antibody Treatment' Helps Reduce Severe Risks of COVID-19, But Why is the FDA Reserving it to Specific People? The Monoclonal Antibody Treatment speaks of a high recovery rate for COVID-19, but the FDA is holding it up for specific reasons.by Isaiah Richard
HealthFacebook Blocks COVID-19 Misinformation Researchers from NYU, Cuts off Access to Ad Libraryby Isabella James
TechCOVID Tech Connect, a Non-Profit Organization, Allows COVID-19 Patients to Call for Free from Any Deviceby Sophie Webster
HealthCOVID-19: University of Pittsburgh Researchers Develop Single-Domain Antibody For SARS-COV-2 Variantsby Joseph Henry
HealthThis U.S. State Has the Worst COVID-19 Hospitalization Rate Among Kids, Teens — Can You Guess Where?by Isabella James
CultureCOVID-19 Quarantine: A Man Ships His $7,000 Gaming Setup to His 14-day Isolation Hotelby Teejay Boris
HealthUNC Students 'Knew How to Buy Fake Vaccine Cards' to Comply with University Shot Requirementby Urian B.
HealthCOVID-19: Unvaccinated Vs. Vaccinated; New X-Ray Images Reveal Alarming Lung Differences in Oxygen Inhalationby Griffin Davis
HealthCOVID-19 Vaccination Proof Will Be Required by NYC for Entertainment, Fitness, Indoor Diningby RJ Pierce
HealthCOVID-19: Oklahoma Man in Need of Double Lung and Heart Transplant After Contracting COVIDby Isabella James